Skip to main content
Livermore
Livermore
ZHEN

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

NVS holding history

Novartis AG in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVS overviewAll 13F holders of NVSFull Q2 2026 holdings

Shares (Q2 2026)
15,640
Value
$2.45M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NVS by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202615,640$2.45M<0.1%−726−4.4%ReducedHolders
Q1 202616,366$2.50M<0.1%+3,742+29.6%AddedHolders
Q4 202512,624$1.74M<0.1%+148+1.2%AddedHolders
Q3 202512,476$1.60M<0.1%+351+2.9%AddedHolders
Q2 202512,125$1.47M<0.1%−706−5.5%ReducedHolders
Q1 202512,831$1.43M<0.1%−1,586−11.0%ReducedHolders
Q4 202414,417$1.40M<0.1%+496+3.6%AddedHolders
Q3 202413,921$1.60M<0.1%+975+7.5%AddedHolders
Q2 202412,946$1.38M<0.1%+896+7.4%AddedHolders
Q1 202412,050$1.17M<0.1%+3,179+35.8%AddedHolders
Q4 20238,871$895.7K<0.1%−235−2.6%ReducedHolders
Q3 20239,106$927.6K<0.1%+298+3.4%AddedHolders
Q2 20238,808$888.8K<0.1%+762+9.5%AddedHolders
Q1 20238,046$740.3K<0.1%+705+9.6%AddedHolders
Q4 20227,341$666.0K<0.1%−63−0.9%ReducedHolders
Q3 20227,404$563.0K<0.1%−771−9.4%ReducedHolders
Q2 20228,175$691.0K<0.1%−2,138−20.7%ReducedHolders
Q1 202210,313$907.0K<0.1%−1,684−14.0%ReducedHolders
Q4 202111,997$1.05M<0.1%−1,900−13.7%ReducedHolders
Q3 202113,897$1.14M<0.1%+2,123+18.0%AddedHolders
Q2 202111,774$1.07M<0.1%+3,484+42.0%AddedHolders
Q1 20218,290$709.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.